Dr. Prakash C. Neupane, MD

Dr. Neupane practices at The University of Kansas Hospital in Kansas City, Kansas, part of The University of Kansas Health System.

Dr. Neupane's NPI, 1700822210, was assigned on June 22, 2006. Dr. Neupane holds Kansas license 0433144.

Dr. Neupane's primary practice is The University of Kansas Hospital, at 4000 Cambridge Street, Kansas City, KS 66160 in Wyandotte County. The practice phone is (913) 588-5000.

Dr. Neupane's primary practice is The University of Kansas Hospital in Kansas City, Kansas, part of The University of Kansas Health System. Dr. Neupane is also affiliated with The University of Kansas Health System Olathe Hospital. The medical group on file is Kansas University Physicians. Dmand AI also links Dr. Neupane to 1 more hospital, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Neupane practices, 4 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Neupane's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Neupane is licensed in Kansas.

CMS data shows 1,422 Medicare services from Dr. Neupane across 5 procedure codes in 2024, for 338 Medicare patients. Medicare paid $96,826 for them.

CMS counts 338 Medicare patients who saw Dr. Neupane in 2024. The largest group is 65 to 74, with 192 patients. 72% of them have high cholesterol, and 71% have high blood pressure. 8% are also on Medicaid. Their average risk score is 2.55, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Neupane's median patient age at 72, with 38% women.

In 2024, Dr. Neupane wrote 1,068 Medicare Part D claims for 197 patients. 79% of them were for generic drugs. CMS names the drug for 793 of them, across 25 drugs with 11 or more claims each, at $1,136,000 in total drug cost. In 2023, CMS named 718 claims across 23 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Neupane for performance year 2024, reported through an alternative payment model (APM). Dr. Neupane accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Neupane as offering telehealth.

CMS Open Payments shows 91 general payments to Dr. Neupane from 14 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 57% of the total. Bristol-Myers Squibb Company paid the most, $30,429.